1.Application of quantitative proteomics in the study of acute mountain sickness.
Bodan TU ; Xue WEI ; Huiying SHANG ; Zuoxu LIU ; Yihao WANG ; Yue GAO
Chinese Journal of Biotechnology 2023;39(9):3594-3604
Acute mountain sickness (AMS) is a clinical syndrome of multi-system physiological disorder after acute exposure to low pressure and low oxygen at high altitude. Quantitative proteomics can systematically quantify and describe protein composition and dynamic changes. In recent years, quantitative proteomics has been widely used in the prevention, diagnosis, treatment and pathogenesis of many diseases. This review summarizes the progress of quantitative proteomics techniques and its application in the prevention, diagnosis, treatment of AMS and mechanisms of rapidly acclimatizing to plateau, in order to provide a reference for the pathogenesis, early intervention, clinical treatment and proteomic research of AMS.
Humans
;
Altitude Sickness/prevention & control*
;
Proteomics
;
Acute Disease
;
Oxygen/metabolism*
2.The study of plasma proteomic changes in a patient with high-altitude cerebral edema.
Yuan-Yuan ZHANG ; Rui-Feng DUAN ; Hai WANG
Chinese Journal of Applied Physiology 2011;27(2):180-184
OBJECTIVEHigh-altitude cerebral edema (HACE) is one of the most serious acute mountain sickness and its underlying mechanism is still unknown clearly. The aim of this study was to determine the changes of plasma proteins in high altitude cerebral edema patients for discovering essential biomarkers used for the routine prophylaxis, diagnosis and treatment.
METHODSPlasma protein profiling two dimensional gel electrophoresis followed by mass spectrometry was used to explore protein alterations in one patient with high-altitude cerebral edema (HACE). Striking differences in two-dimensional gel proteomes of plasma were observed between high-altitude cerebral edema (HACE) and high-altitude pulmonary edema (HAPE) and between high-altitude cerebral edema (HACE) and mild acute mountain sickness (mAMS). Furthermore, apolipoprotein E altered in high-altitude cerebral edema was validated by ELISA.
RESULTSDifferent six spots were found in this study from the comparison between HACE and HAPE, and there were different six spots which were detected from the plasma of HACE patient in comparison to mAMS. Apolipoprotein E was identified in the two groups of comparative maps and results of ELISA consisted with the results of 2-DE.
CONCLUSIONIn this study, we used proteomic approach to explore HACE firstly and found different proteins that were probably associated with HACE. This would offer a clue to a better understanding of HACE for precaution, diagnosis and treatment.
Adult ; Altitude ; Altitude Sickness ; complications ; Apolipoproteins E ; blood ; Blood Proteins ; metabolism ; Brain Edema ; blood ; etiology ; Female ; Humans ; Proteomics ; methods
3.Expression of GATA-1 and GATA-2 in the bone marrow of patients with Monge's disease.
Jian-ping LI ; Nai-yong JIA ; Zhan-quan LI ; Hong-xin WANG ; Juan SU ; Yu-li LI ; Xue-mei LI
Chinese Journal of Hematology 2007;28(8):537-540
OBJECTIVETo find out how GATA-1 and GATA-2 behave in the bone marrow of patients with Monge's disease.
METHODSThe levels of mRNA in mononuclear cells (MNC) and proteins of GATA-1 and GATA-2 in the bone marrow of patients with Monge's disease and controls were determined by RT-PCR and immune cytolysis chemical method.
RESULTS(1) All patients and controls expressed GATA-1 mRNA (Monge's disease 1.033 +/- 0.146, Control 0.458 +/- 0.076) and GATA-2 mRNA (Monge's disease 0.451 +/- 0.073, Control 0.185 +/- 0.074). All patients expressed both GATA-1 (positive cell counts 77.3 +/- 33.3, positive score 135.4 +/- 75.4) and GATA-2 ( positive cell counts 29.4 +/- 11.4, positive score 48.4 +/- 19.7). All the controls expressed GATA-1 (positive cell counts 18.1 +/- 11.3, positive score 24.2 +/- 13.4) while 12 of 20 controls expressed GATA-2 ( positive cell counts 5.4 +/- 3.0, positive score 7.3 +/- 4.2). The expression of mRNA and proteins of GATA-1 and GATA-2 in Monge's disease were higher than in controls (P < 0.01). (2) There was a positive correlation between GATA-1 and Hb (P < 0.01), as did between mRNA and proteins of GATA-1 and GATA-2. (3) Both the proteins of GATA-1 and GATA-2 located only in the cytoplasm but not the nucleus.
CONCLUSIONSTwo of inherent genes, GATA-1 and GATA-2 which were expressed at higher levels in patients with Monge's disease than in controls might play significant roles in the pathogenesis of Monge's disease.
Adult ; Altitude Sickness ; metabolism ; GATA1 Transcription Factor ; metabolism ; GATA2 Transcription Factor ; metabolism ; Humans ; Male ; Polycythemia ; metabolism ; RNA, Messenger ; metabolism
4.ACE2-Ang-(1-7)-Mas axis level of local bone marrow in chronic mountain sickness patients.
Hongli ZHANG ; Linhua JI ; Zhanquan LI ; Sen CUI ; Juan SU ; Hui GENG ; Wei LUO ; Jie MA ; Xiaojing MA ; Yujuan YIN ; Yuanqing CHEN
Chinese Journal of Hematology 2014;35(7):658-660
Adult
;
Aged
;
Altitude Sickness
;
metabolism
;
Bone Marrow
;
metabolism
;
Chronic Disease
;
Humans
;
Male
;
Middle Aged
;
Peptide Fragments
;
metabolism
5.Investigation of hyperbaric oxygen preconditioning on anoxic resistance and anti-weariness at high altitude.
Jian-hua CUI ; Liang GAO ; Xi-zhou ZHANG ; Xiang-hua JIN ; Bin LI ; Zhen-de HA ; Wei WANG ; Guang-quan MA
Chinese Journal of Applied Physiology 2008;24(4):444-447
AIMTo explore the influence of hyperbaric oxygen (HBO) preconditioning on anoxic resistance and anti-weariness at high altitude.
METHODS(1) SOD, MDA, NO, NOS, BLA and BUN of 20 youths living at 3 700 m altitude for half year were tested, then they were divided into group A (n=10, received HBO pretreatment twice) and group B (n=10, received HBO pretreatment 5 times) randomly. They were asked to pedal the EMG-bicycle-ergometer at the second and eighth day, and then the same items were tested. (2) 29 youth who would go to Astronomical Spot (5200 m) were randomly divided into group HBO (n=11, received HBO pretreatment once per day for 2 days at Yecheng (1400 m)) and comparison group (n=10). When they reached I Astronomical Spot, thematic biochemical index were investigated. (3) When 20 youth reached Thirty Milepost Barracks (3700 m) at the second day in their way to Immortal Gulf (5380 m) from Yecheng were randomly divided into group HBO (n=10, received HBO pretreatment once per day for 3 days) and comparison group (n=10). When they reached Immortal Gulf, the thematic biochemical index were investigated.
RESULTS(1) SOD, NO, NOS were increased and BLA, BUN, MDA were decrease in group A compared with that in group B until the eighth day, there was significant difference (P < 0.01). (2) SOD, NO, NOS were increased and BLA, BUN, MDA were decrease in group HBO compared with that in comparison that in group, there was significant difference between groups (P < 0.01, or P < 0.05).
CONCLUSIONHBO could enhance the activity of anti-oxidase and the cleared ability of lactic acid, and the effect of anti-weariness could last for 8 days.
Altitude ; Altitude Sickness ; prevention & control ; Fatigue ; prevention & control ; Humans ; Hyperbaric Oxygenation ; methods ; Hypoxia ; physiopathology ; Ischemic Preconditioning ; methods ; Male ; Oxidative Stress ; drug effects ; physiology ; Superoxide Dismutase ; metabolism ; Young Adult
6.Relationship of high altitude de-adaptation with acute high altitude response and cardiac function.
Sheng-Yue YANG ; Qi-Quan ZHOU ; En-Zhi FENG ; Zi-Qiang YAN ; Zhong-Xin TIAN ; He YIN ; Zi-Fu SHI
Chinese Journal of Applied Physiology 2013;29(5):395-399
OBJECTIVETo assess the relationship of high altitude de-adaptation response (HADAR) with acute high altitude response (AHAR) and cardiac function.
METHODSNinety-six military personnel of rapid entering into high altitude (3 700 to 4 800 m) with strong physical work were analyzed, all subjects were male, aged 18 - 35 years. According to the symptomatic scores of AHAR were divided into 3 groups: sever AHAR (group A, 24), mild to moderate AHAR (group B, 47) and non-AHAR (group C, 25) at high altitude. According to the symptomatic scores of HADAR were divided into 3 groups: severe HADAR (group E, 19), mild to moderate HADAR (group F, 40) and non-HADAR (group G, 37) after return to lower altitude (1 500 m). Mean pulmonary arterial pressure (mPAP), right ventricular internal dimension (RVID), outflow tract of right ventricle (RVOT), left ventricular internal dimension (LVID), left ventricular ejection fraction (LVEF), cardiac muscle work index (Tei index), creatine kinase isoenzymes-MB (CK-MB), lactic dehydrogenase isoenzyme-1 (LDH-1) were measured at high altitude stayed 50 days and after return to lower altitude 12 h, 15 d, and 30 d. Fifty healthy volunteers (group D) at 1 500 m altitude served as control.
RESULTSLevel of mPAP, RVID, RVOT, RVID/LVID ratio, Tei index, CK-MB,and LDH-1 were higher, and LVEF was lower in group A than those in group B, C and D, there were significant differences between group B and C, C and D (all P < 0.01). AHAR scores were positively correlated with HADAR scores (r = 0.863, P < 0.01). Twelve hours after return to lower altitude, level of mPAP, RVID, RVOT, RVI/LVID ratio, Tei index, CK-MB, and LDH-1 were higher, and LVEF was lower in group E than those in group F, G and D, there were significant differences between group F and G, G and D (all P < 0.01). Fifteen days after return to lower altitude, level of mPAP, RVID, RVOT, RVID/LVID ratio were higher in group E than those in group F, G, and D, there were significant differences between group F and G, and D (P < 0.01 or P < 0.05), there were no significant differences between group G and D (all P > 0.05), LVEF, Tei index, CK-MB, LDH-1 showed no significant differences among groups (all P > 0.05). Thirty days after return to lower altitude, these parameters in group E, F, and G showed no significantly differences compared with those of group D (all P > 0.05).
CONCLUSIONThe severity of HADAR is associated with severity of AHAR and cardiac injury, the more serious of AHAR and cardiac injury at high altitude, the more serious of HADAR and cardiac injury after return to lower altitude, the more long of restore of right cardiac morphologic injury.
Adaptation, Physiological ; Adolescent ; Adult ; Altitude ; Altitude Sickness ; metabolism ; physiopathology ; Case-Control Studies ; Heart ; physiopathology ; Heart Function Tests ; Humans ; Male ; Myocardium ; enzymology ; Young Adult
7.Apparatus for the measurement of the oxygen uptake of rats subjected to hypobaric hypoxia.
Rui-Feng DUAN ; Wen-Kao NAN ; Yi-Ping XING ; Huai-Xin WANG ; Wen-Yu CUI ; Hai WANG
Chinese Journal of Applied Physiology 2011;27(4):507-509
OBJECTIVETo construct an apparatus for the oxygen uptake measurement of rats exposed to hypobaric hypoxia at different simulated altitude.
METHODSThe capacity of this apparatus was about 0.01 m3. It included animal experimental cabin, reference cabin, altimeter, altitude vertical velocity indicator, pressure difference inductor and oxygen compensator, low scale manometer, soda lime and calcium chloride, small fan, thermometer, circulating water system and vacuum pump. The oxygen uptake of the rats at 6 000 m, 4 000 m and 1 000 m simulated altitude was measured using this apparatus.
RESULTSThe oxygen uptake of the rats at 50 m, 4 000 m and 6 000 m simulated altitude was (24.4 +/- 2.1), (10.8 +/- 2.0) and (8.8 +/- 1.6) ml O2/(kg x min) respectively (average +/- s, n = 10). The oxygen uptake decreased as altitude increased.
CONCLUSIONThis apparatus can be used to measure the oxygen uptake of the rats at different simulated altitude.
Altitude ; Altitude Sickness ; physiopathology ; Animals ; Computer Simulation ; Equipment and Supplies ; Hypoxia ; physiopathology ; Male ; Oxygen ; metabolism ; Oxygen Consumption ; physiology ; Rats ; Rats, Sprague-Dawley
9.Expression of Key Enzymes in Glucose Metabolism in Chronic Mountain Sickness and Its Correlation with Phenotype.
Yun-Mei GAO ; Guo-Xiong HAN ; Cheng-Hui XUE ; Lai-Fu FANG ; Wen-Qian LI ; Kuo SHEN ; You-Bang XIE
Journal of Experimental Hematology 2023;31(1):197-202
OBJECTIVE:
To explore the pathogenesis of erythrocytosis by detecting the key enzymes of glucose metabolism and glucose transporter in bone marrow erythrocytes of chronic mountain sickness (CMS), and analyzing its correlation with hemoglobin.
METHODS:
Twenty CMS patients hospitalized in Qinghai Provincial People's Hospital from January 2019 to December 2020 were selected as CMS group. Twenty males with leukocyte count > 3.5×109/L who had accepted bone marrow aspiration and had normal result were taken as control group. The mRNA and protein expression of key enzymes and glucose transporter in glucose metabolism in bone marrow CD71+ erythrocytes were detected by real time qPCR and Western blot, respectively. Glucose, lactic acid and 2,3-diphosphoglycerate in the bone marrow supernatant and serum were tested by ELISA. The mRNA and protein expression of key enzymes and glucose transporter, glucose, lactic acid and 2,3-diphosphoglycerate of the two groups were compared. Pearson correlation was used to analyze the correlation between key enzymes, glucose transporter in glucose metabolism in bone marrow CD71+ erythrocytes and hemoglobin.
RESULTS:
The expression of HK2, GLUT1 and GLUT2 mRNA in the CMS group were higher than those in the control group (P<0.001), while the expression of HK1, OGDH and COX5B mRNA were not different. The expression of HK2, GLUT1 and GLUT2 protein in the CMS group were higher than those in the control group (P<0.05). The levels of glucose and lactic acid in the bone marrow supernatant and serum in the CMS group were not different from those in the control group, while the level of 2,3-diphosphoglycerate was higher (P<0.001). Both HK2 and GLUT2 proteins were positively correlated with hemoglobin (r=0.511, 0.717).
CONCLUSION
CMS patients may increase glycolysis by increasing the expression of HK2, and promote the utilization of glucose through high expression of GLUT1 and GLUT2 to meet the need of energy supply.
Male
;
Humans
;
Altitude Sickness/metabolism*
;
Glucose Transporter Type 1
;
2,3-Diphosphoglycerate
;
Hemoglobins
;
Chronic Disease
;
RNA, Messenger
;
Phenotype
;
Glucose
10.Correlation and influences of inflammatory mediators on permeability of the blood-brain barrier at high altitude exposure.
Qi-Quan ZHOU ; Jing WANG ; Yun-Li WANG ; Ai-Dong LI ; Li CHENG
Chinese Journal of Applied Physiology 2007;23(3):281-285
AIMTo investigate the influences of inflammatory mediator on permeability of the blood-brain barrier(BBB) at high altitude environmental exposure as well as relationship and water content in brain.
METHODSWistar rats were exposed to different altitude gradients, then brain tissue homogenate was prepared, and the activities of tumor necrosis factor-alpha (TNFalpha) and endothelin (ET) in brain tissue homogenate were measured by radioimmunoassay methods. The activities of nitric oxide (NO) in brain tissue homogenate were measured by chemical methods. The evans blue (EB) content in brain tissue was determined by colorimetry and the wet weight/dry weight ratio (W/D) was used to express the water content in brain.
RESULTSWith altitude going up, the activities of TNFalpha, NO and ET in the brain of rats rose, and they also rose gradually with time prolonging under high altitude hypoxia exposure. Their most obvious rise was seen during 9 days after ascending 5 000 m high altitude regions. At the same time, the EB and water content in the brain of mice showed the same change trends. Therefore, the inflammatory mediator activity and EB content as well as water content in brain showed an evidently linear relationship.
CONCLUSIONThe inflammatory mediator plays an important role in the change of permeability of BBB. It's a critical inducing factor in the change of permeability of BBB under high altitude exposure.
Altitude ; Altitude Sickness ; metabolism ; Animals ; Blood-Brain Barrier ; physiology ; Brain Edema ; etiology ; metabolism ; Capillary Permeability ; Cerebrovascular Circulation ; Endothelins ; metabolism ; Female ; Hypoxia ; metabolism ; Inflammation Mediators ; physiology ; Male ; Nitric Oxide ; metabolism ; Permeability ; Rats ; Rats, Wistar ; Tumor Necrosis Factor-alpha ; metabolism